Novavax Inc. (NVAX) Quarterly Performance is 44.15%: Here is the Surprise Factor – Invest Chronicle
Home  »  News   »  Novavax Inc. (NVAX) Quarterly Performance is 44.15...

Novavax Inc. (NVAX) Quarterly Performance is 44.15%: Here is the Surprise Factor

For the readers interested in the stock health of Novavax Inc. (NVAX). It is currently valued at $194.99. When the transactions were called off in the previous session, Stock hit the highs of $184.97, after setting-off with the price of $183.00. Company’s stock value dipped to $172.22 during the trading on the day. When the trading was stopped its value was $175.65.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Recently in News on April 8, 2021, Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference. Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in a fireside chat during the Goldman Sachs Recovery Inoculated: The Current Outlook for COVID-19 Vaccines, Treatments, Testing and the Economy virtual conference. Novavax’ COVID-19 vaccine candidate, NVX-CoV2373, will be a topic of discussion. You can read further details here

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!


Novavax Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $331.68 on 02/09/21, with the lowest value was $109.01 for the same time period, recorded on 01/04/21.

Novavax Inc. (NVAX) full year performance was 930.21%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Novavax Inc. shares are logging -41.21% during the 52-week period from high price, and 1088.27% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $16.41 and $331.68.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3116727 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Novavax Inc. (NVAX) recorded performance in the market was 57.52%, having the revenues showcasing 44.15% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 12.72B, as it employees total of 791 workers.

The Analysts eye on Novavax Inc. (NVAX)

During the last month, 5 analysts gave the Novavax Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 172.11, with a change in the price was noted +106.84. In a similar fashion, Novavax Inc. posted a movement of +117.86% for the period of last 100 days, recording 4,380,183 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for NVAX is recording 0.75 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.58.

Technical rundown of Novavax Inc. (NVAX)

Raw Stochastic average of Novavax Inc. in the period of last 50 days is set at 27.19%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 46.61%. In the last 20 days, the company’s Stochastic %K was 30.59% and its Stochastic %D was recorded 24.34%.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Considering, the past performance of Novavax Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 57.52%. Additionally, trading for the stock in the period of the last six months notably improved by 58.21%, alongside a boost of 930.21% for the period of the last 12 months. The shares increased approximately by -0.93% in the 7-day charts and went up by -6.38% in the period of the last 30 days. Common stock shares were driven by 44.15% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

We do not sell or share your information with anyone.